PATENT CLAIM ANALYSIS

Application Number: 16383623
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-08
Patent Classification: ["546", "201000"]

Abstract:
The present invention relates to particulate forms of anamorelin monohydrochloride or a composition comprising anamorelin monohydrochloride having controlled chloride content, preferably isolated in an amorphous and/or fine particulate state, processes for making the particulate forms, and pharmaceutical compositions comprising the particulate forms.

Claim (Index 41):
A pharmaceutical dosage form comprising the anamorelin monohydrochloride of  claim 26  in combination with one or more pharmaceutically acceptable excipients in the form a tablet or capsule or pellets or granules or powders.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 100.0
- Lexical Diversity: 1.31429
- Patent Class: 546.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14539318', '15135147', '15135051', '15135107', '15963284']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8222538234201737
- 35 USC 102 Novelty (BERT): 0.5464507747983032
- Combined Prediction Score: 0.7946735185579866
- Mean Citation Score: 403.991592
- Max Citation Score: 423.68542
- Similarity Product: 341.04434091680173

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test